−Removed: have leased two facilities in Acton, Massachusetts, one which is month-to-month beginning March 2025 and the other will expire in March
−Removed: President and Chief Executive Officer and his spouse, who is also a director of our Company, serve as officers and/or directors of two
−Removed: business entities that are unaffiliated with us (Canary, Inc.
−Removed: and Laminar Pharma, Inc.), and we permit these entities to use our main
−Removed: facility as their registered business address.
−Removed: Chief Technology Officer majority owned business entity (NanoHybrids, Inc.) is permitted to use our laboratory facility.
−Removed: entity for the part-time use of our personnel at a rate of the respective employee’s fully burdened personnel cost, plus an additional
−Removed: 10% fee for use of the facility.
+Added: We have leased two facilities in Acton, Massachusetts,
+Added: one which is month-to-month beginning March 2025 and the other will expire in March 2027.
+Added: Our President and Chief Executive Officer and
+Added: his spouse, who is also a director of our Company, serve as officers and/or directors of Laminar Pharma, Inc., a business that is unaffiliated
+Added: with us, and we permit this entity to use our main facility as its registered business address.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.